David Hirsch, Alpha-9 Oncology CEO
October 23, 2024 10:58 AM EDT
Financing
Startups

Ra­dio­phar­ma star­tups stay hot as Al­pha-9 bags $175M Se­ries C

Max Gelman

Senior Editor

An­oth­er pri­vate ra­dio­phar­ma­ceu­ti­cal biotech has raised big mon­ey.

Al­pha-9 On­col­o­gy re­vealed on Wednes­day that it’s put to­geth­er a $175 mil­lion Se­ries …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Al­to Neu­ro­science's mid-stage tri­al miss­es pri­ma­ry end­point in de­pres­sion

Mer­ck pays $30M to buy ‘chameleon’ ap­proach to dead­ly brain can­cers

Eye drop mak­er to merge with a reti­nal gene ther­a­py start­up from Spark co-founder

'It’s not right.' Califf slams phar­ma over weight loss drug prices

Life sci­ences in­vestor Di­men­sion seeks to raise $500M sec­ond fund

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times